Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 21, 2012
Pharmacokinetics and pharmacodynamics of once-daily versus twice-daily raltegravir in treatment-naive HIV-infected patients
Matthew L Rizk, Yaming Hang, Wen-Lin Luo, et al.
Clinical Pharmacology and Therapeutics
|
February 21, 2023
Opportunities and Challenges of Disease Progression Modeling in Drug Development - An IQ Perspective
Kosalaram Goteti, Nathan Hanan, Mindy Magee, et al.
Journal of Psychiatric Research
|
June 14, 2023
Altered brain function in patients with acrophobia: A voxel-wise degree centrality analysis
Meilin Guo, Yuan Zhong, Jingren Xu, et al.
Clinical Pharmacology and Therapeutics
|
March 13, 2025
Establishment of a Biomarker-Directed Clinical Endpoint Model for Early-Stage Parkinson's Disease Patients
Churni Gupta, Chaejin Kim, Serge Guzy, et al.
Journal of Sleep Research
|
March 19, 2023
Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals
Rebecca Evans, Haruhide Kimura, Masato Nakashima, et al.
Journal of Psychiatry & Neuroscience : JPN
|
March 4, 2025
Impulse control deficits among patients with nonsuicidal self-injury: a mediation analysis based on structural imaging
Ya Xie, Sichu Wu, Jian Li, et al.
Anesthesiology
|
January 13, 2025
TAK-925 (Danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-induced Respiratory Depression and Sedation without Affecting Analgesia in Healthy Men
Maarten van Lemmen, Albert Dahan, Yaming Hang, et al.
The New England Journal of Medicine
|
May 14, 2025
Oveporexton, an Oral Orexin Receptor 2-Selective Agonist, in Narcolepsy Type 1
Yves Dauvilliers, Giuseppe Plazzi, Emmanuel Mignot, et al.
Comprehensive Psychiatry
|
May 7, 2024
Neural mechanism of non-adaptive cognitive emotion regulation in patients with non-suicidal self-injury
Author Nan Lang, Yuan Zhong, Wenkun Lei, et al.
Nature
|
June 23, 2017
Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Antimicrobial Agents and Chemotherapy
|
March 21, 2012
Pharmacokinetics and pharmacodynamics of once-daily versus twice-daily raltegravir in treatment-naive HIV-infected patients
Matthew L Rizk, Yaming Hang, Wen-Lin Luo, et al.
Clinical Pharmacology and Therapeutics
|
February 21, 2023
Opportunities and Challenges of Disease Progression Modeling in Drug Development - An IQ Perspective
Kosalaram Goteti, Nathan Hanan, Mindy Magee, et al.
Journal of Psychiatric Research
|
June 14, 2023
Altered brain function in patients with acrophobia: A voxel-wise degree centrality analysis
Meilin Guo, Yuan Zhong, Jingren Xu, et al.
Clinical Pharmacology and Therapeutics
|
March 13, 2025
Establishment of a Biomarker-Directed Clinical Endpoint Model for Early-Stage Parkinson's Disease Patients
Churni Gupta, Chaejin Kim, Serge Guzy, et al.
Journal of Sleep Research
|
March 19, 2023
Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals
Rebecca Evans, Haruhide Kimura, Masato Nakashima, et al.
Journal of Psychiatry & Neuroscience : JPN
|
March 4, 2025
Impulse control deficits among patients with nonsuicidal self-injury: a mediation analysis based on structural imaging
Ya Xie, Sichu Wu, Jian Li, et al.
Anesthesiology
|
January 13, 2025
TAK-925 (Danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-induced Respiratory Depression and Sedation without Affecting Analgesia in Healthy Men
Maarten van Lemmen, Albert Dahan, Yaming Hang, et al.
The New England Journal of Medicine
|
May 14, 2025
Oveporexton, an Oral Orexin Receptor 2-Selective Agonist, in Narcolepsy Type 1
Yves Dauvilliers, Giuseppe Plazzi, Emmanuel Mignot, et al.
Comprehensive Psychiatry
|
May 7, 2024
Neural mechanism of non-adaptive cognitive emotion regulation in patients with non-suicidal self-injury
Author Nan Lang, Yuan Zhong, Wenkun Lei, et al.
Nature
|
June 23, 2017
Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Page
of 4